Alliance Pharma has strengthened its US consumer health offering by striking a deal with Perrigo Company for its scar treatments ScarAway and Kelo-cote.
Having previously revealed acquisition discussions were underway, UK-based Alliance confirmed it had paid Perrigo $19.4m in cash for ScarAway and...





